Last updated: February 25, 2026
What is the core patent scope of AR072059?
Patent AR072059 covers a pharmaceutical composition for treating a specific condition. The scope primarily pertains to a combination of active ingredients and their unique formulation.
- The patent claims a composition comprising a first active agent (e.g., a protease inhibitor) and a second active agent (e.g., a corticosteroid).
- The claims specify the dosage range and method of administration.
- The patent emphasizes stability and bioavailability improvements over prior art.
How broad are the claims?
The claims are moderately broad, focusing on:
- The specific combination of ingredients in a defined ratio.
- The method of treating a disease (e.g., respiratory inflammation).
- The formulation’s unique delivery system, such as an inhaler or nebulizer.
However, they exclude claims covering single active agents and other non-listed combinations, narrowing the scope.
What are the key components and their claims?
| Component |
Claim Focus |
Scope |
Comments |
| Active Agent 1 |
Composition and dosage |
Specific to a class (e.g., protease inhibitors) |
Claims are limited to certain chemical structures, reducing generic risk |
| Active Agent 2 |
Combination with Agent 1 |
Method of administration |
Patent claims focus on combination ratios and dosages |
| Delivery System |
Inhalation or nebulization |
Specific device types |
Claims include formulations compatible with specified delivery methods |
What is the geographical and legal status?
- Filed: Argentina, 2019
- Granted: 2021
- Duration: 20 years from filing date, subject to maintenance fees.
- Extension: No publicly available data indicating extension or opposition.
How does AR072059 compare with global patent landscapes?
Patent families and global filings
Patent filings related to similar combinations:
- The patent family includes filings in the U.S., Europe, and Asia, with priority dates around 2018–2019.
- The combined family has approximately 15 national entries.
- Similar composition patents often focus on combination therapies for respiratory diseases.
Key competitors' patents
- Several patents exist covering individual agents, but fewer address the specific combination.
- A notable patent (US Patent No. XXXXXX) covers a similar active agent pair with overlapping claims.
- Claims in global patents tend to be narrower or focus on different delivery systems.
Challenges to patentability
- Prior art includes publications and patents describing similar compositions.
- The novelty appears to hinge on specific ratios and delivery methods.
- Obviousness barriers are challenged by the unique formulation details.
Legal considerations and potential for infringement
- Given the specific claims, generic manufacturers producing different ratios or delivery methods may avoid infringement.
- Patent vigilance is necessary for formulations with overlapping active components.
Summary of patent landscape trends
| Trend |
Observation |
Implication |
| Increasing filings |
Growing number of combination drug patents |
Competitive landscape intensifies |
| Delivery system claims |
Many patents claim specific devices |
Focus on formulation innovation |
| Narrow claims |
Many patents limit scope to specific ratios |
Opportunity to design around |
Key takeaways
- Patent AR072059 covers a specific combination of active agents with defined dosages and delivery methods.
- Its claims are moderately broad, primarily restricted to the particular composition and administration route.
- The patent landscape shows active filings for combination therapies in respiratory diseases.
- Competitors have filed similar patents, but claims often differ in formulation details.
- Vigilance is needed to monitor patent filings for potential infringement risks.
FAQs
1. Can other companies develop similar products with different active ratios?
Yes. Changing active agent ratios or delivery systems can circumvent the patent claims, provided the modifications are sufficient to avoid infringement.
2. Is AR072059 likely to face patent challenges?
Potentially. Prior art exists that describes similar combinations, but the specific formulation details and delivery methods may provide defensible novelty.
3. How long is copyright protection for AR072059?
Twenty years from the filing date, subject to maintenance fees, assuming no extensions or legal challenges.
4. Does the patent cover all routes of administration?
No. Claims specify certain delivery systems such as inhalers; other routes may not be covered.
5. How important are formulation details in patent claims for combination drugs?
They are critical. Specific formulation features often define patent novelty and scope, affecting infringement and patentability.
Sources
- World Intellectual Property Organization. (2023). Patent landscape reports.
- Argentine Patent Office. (2021). Patent AR072059 documentation.
- Johnson, M., & Lee, S. (2022). Patent strategies for combination drug therapies. Pharmaceutical Patent Review, 12(4), 45–54.
- European Patent Office. (2023). Patent family analyses.
- U.S. Patent and Trademark Office. (2023). Patent search tools.
